Live Breaking News & Updates on Regence Health Plans

Stay updated with breaking news from Regence health plans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm


Press release content from PR Newswire. The AP news staff was not involved in its creation.
New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm
May 11, 2021 GMT
(PRNewsfoto/Tabula Rasa HealthCare)
MOORESTOWN, N.J., May 11, 2021 /PRNewswire/ Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medication, and Regence Health Plans today announced the results of a simulation-based clinical study which demonstrates that TRHC’s MedWise® medication risk score can be used to assess drug safety without exposing real people to actual harm.
The study, published online in Clinical and Translational Science, used TRHC’s proprietary MedWise medications safety technology to virtually assess the potential risk of adverse drug events (ADEs) when adding repurposed drugs for COVID-19 treatment to the individual medications of a large-scale population. The results demonstrate ....

United States , Veronique Michaud , Calvinh Knowlton , Matthew Hafermann , Regence Health Plan , Tabula Rasa Healthcare Inc , Regence Health , Prnewswire Tabula Rasa Healthcare Inc , Development Institute , Precision Pharmacotherapy Research , Blue Shield Association , Rasa Healthcare , Regence Health Plans , Translational Science , Medwise Risk Score , Chief Operating Officer , Wise Advisor , Each Regence , Blue Cross , Blue Shield , ஒன்றுபட்டது மாநிலங்களில் , வெரோனிக் மைக்கேட் , ரீஜன்ஸ் ஆரோக்கியம் திட்டம் , அட்டவணை ராசா சுகாதாரம் இன்க் , ரீஜன்ஸ் ஆரோக்கியம் , வளர்ச்சி நிறுவனம் ,